Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots - 19 days ago
2	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	GLP1 Agonists and Dietary Fiber May Reduce VTE Risk and Improve GVHD Outcomes - 20 days ago
3	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Pharma giants vie for oral GLP-1R approval - 25 days ago Vivolta and Neurochase to produce brain therapy catheters - about 1 month ago Boehringer Ingelheim’s survodutide shows promise in liver fibrosis treatment - 7 months ago
4	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Milk-based therapies could be coming. This biotech CEO is aiming to lead the way. - 25 days ago A diabetes drug, twice rejected, stumbles again — but its developer persists - about 2 months ago To penetrate crowded GLP-1 field, Rivus Pharma is taking a metabolic approach - 9 months ago
5	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Arrowhead Pharmaceuticals Submits FDA Application for Plozasiran in Familial Chylomicronemia Syndrome - about 1 month ago FDA Grants Breakthrough Device Designation for System Maintaining Weight Loss After GLP-1 - 5 months ago FDA Approves Cerliponase Alfa for Expanded Indication of CLN2 Disease - 5 months ago Compounded, Counterfeit Semaglutide Poses Severe Risk to Patients - 8 months ago Investigational GLP-1 Medication Found to Reduce Body Weight - 10 months ago Celltrion Seeks Approval From FDA for CT-P47 as Biosimilar of Tocilizumab - 11 months ago Proposed Biosimilar Liraglutide Shows Non-Inferiority to Reference Drug for Type 2 Diabetes - 12 months ago New Synthetic Molecule Shows Promise in Treatment of Heart Failure - about 1 year ago
6	Tara Haelle MedPage Today Sci/health journalist. Feminist. Educator. Photographer. Author. DFW science journalismhealthphotographyteaching	Rifaximin Reduced Overt Hepatic Encephalopathy Recurrence Over Lactulose - about 2 months ago
7	Carly Cassella Science Alert Writer at ScienceAlert. Sciencewriting	One Type of Fiber May Have Weight Loss Benefits Similar to Ozempic - 2 months ago One Type of Fiber Could Have Weight Loss Benefits Similar to Ozempic - 5 months ago
8	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Continuous Parkinson's Disease Therapy Wins FDA Nod - 2 months ago
9	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	An Alzheimer’s drugmaker is accused of data ‘manipulation.’ Should its trials be stopped? - 3 months ago
10	Aislinn Antrim, Assistant Managing Editor Pharmacy Times Journalist at Pharmacy Times. UNC graduate. PoliticsStorytellingCats	FDA Grants Breakthrough Therapy Designation to Plozasiran for Familial Chylomicronemia Syndrome - 4 months ago

Journalists covering Circulose